stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. MGRX
    stockgist
    HomeTop MoversCompaniesConcepts
    MGRX logo

    Mangoceuticals, Inc.

    MGRX
    NASDAQ
    Healthcare
    Medical - Healthcare Information Services
    Dallas, TX, US3 employeesmangorx.com
    $0.34
    -0.02(-4.94%)

    Mkt Cap $4M

    $0.16
    $2.74

    52-Week Range

    At a Glance

    AI-generated

    Challenging year marked by deepening operating losses and a 26% revenue decline as the company struggled to commercialize its telemedicine platform, offset only by aggressive equity financing that provided temporary liquidity but diluted shareholders significantly.

    $4M

    Market Cap

    $463.3K

    Revenue

    -$20M

    Net Income

    Employees3
    Fundamentals

    How The Business Makes Money

    Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

    Industry Medical - Healthcare Information Services
    Activity

    What Changed Recently

    Delisting
    Feb 5, 2026

    (a) of Form 8-K that the Company publicly disclose the deficiency within four (4) business days after the date of the deficiency letter. SIGNATURES Pursuant to

    Regulation FD
    Feb 22, 2026

    by reference. The information in this Item 7.01 , including Exhibit 99.1 attached hereto, shall not be deemed “ filed ” for purposes of Section 18 of the Securi

    Regulation FD
    Feb 18, 2026

    by reference. The information in this Item 7.01 , including Exhibit 99.1 attached hereto, shall not be deemed “ filed ” for purposes of Section 18 of the Securi

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    PALIPalisade Bio, Inc.$1.90+0.80%$314M-6.3
    TOIThe Oncology Institute, I...$3.13-0.16%$310M-53.7
    CINGCingulate Inc.$6.20+3.08%$35M-1.7
    ENTOENTO$2.85-5.00%$14M—
    FEMYFemasys Inc.$0.44+4.84%$13M-0.8
    VSEEVSee Health, Inc.$0.22-5.57%$4M-0.3
    ASBPAspire Biopharma Holdings...$0.97-3.96%$3M—
    HCTIHealthcare Triangle, Inc.$2.42-4.53%$3M-0.0
    Analyst View
    Company Profile
    CIK0001938046
    ISINUS56270V2051
    CUSIP56270V106
    Phone(214) 242-9619
    Address15110 North Dallas Parkway, Dallas, TX, 75248, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice